Travel & financial grants

Blood Cancer United

The Susan Lang Pay-It-Forward Travel Assistance Program, sponsored by Blood Cancer United, provides financial help for ground transportation, tolls, gas, parking, car rental, vehicle repairs, airfare, baggage fees, lodging, and ambulance services. Applicants must have a confirmed blood cancer diagnosis, reside in the US or US territories, and have an income at or below 500% of the Federal Poverty Guidelines. To apply, individuals should call the provided number, with funds subject to availability.

Blood Cancer United

The Blood Cancer United Susan Lang Pay-It-Forward Travel Assistance Program provides financial assistance for various travel expenses, including ground transportation, airfare, lodging, and ambulance services. Applicants must reside in the US or US territories, have a confirmed blood cancer diagnosis, and an income at or below 500% of the Federal poverty guidelines.

Blood Cancer United

The Susan Lang Pay-It-Forward Travel Assistance Program, sponsored by Blood Cancer United, provides financial assistance for ground transportation, airfare, lodging, and other travel-related expenses. It is available to applicants with a confirmed blood cancer diagnosis who live in the US or US territories and have an income at or below 500% of the Federal poverty guidelines.

Blood Cancer United

The Susan Lang Pay-It-Forward Travel Assistance Program offers financial assistance for a wide range of travel-related expenses including ground transportation, flights, lodging, tolls, gas, parking, car rental, vehicle repairs, baggage fees, and ambulance services. Applicants must have a confirmed blood cancer diagnosis, live in the US or US territories, and have an income at or below 500% of the Federal poverty guidelines.

Blood Cancer United

The Susan Lang Pay-It-Forward Travel Assistance Program provides assistance for ground transportation, tolls, gas, parking, car rental, vehicle services/repairs/parts, airfare, baggage fees, lodging, and ambulance services. Applicants must live in the US or US territories, have a confirmed blood cancer diagnosis, and an income at or below 500% of the Federal poverty guidelines. Funds are subject to availability.

Blood Cancer United

The Susan Lang Pay-It-Forward Travel Assistance Program, offered by Blood Cancer United, provides financial help for a wide range of travel expenses, including ground transportation, airfare, lodging, and ambulance services. Applicants must have a confirmed blood cancer diagnosis, reside in the US or US territories, and have an income at or below 500% of the Federal poverty guidelines.

The Assistance Fund

The TAF Financial Assistance Program for MPS II (Hunter Syndrome) provides financial assistance for out-of-pocket costs including prescription drug copays, health insurance premiums, therapy administration, genetic testing, and travel expenses like ground transportation, air travel, meals, and hotel stays to treatment centers or physicians. Eligible patients must be U.S. citizens or permanent residents, diagnosed with MPS II, prescribed an FDA-approved treatment with prescription coverage, and meet financial eligibility based on household income and size. The program is currently operating on a waitlist basis.

Taiho Oncology

The Taiho Oncology Patient Support program offers financial assistance, including a $0 co-pay, for eligible commercially insured patients receiving INQOVI for MDS. The program focuses on medication costs and reimbursement, but does not cover travel-related expenses.

Takeda Oncology

The Takeda Oncology Here2Assist program offers financial assistance to help eligible patients afford the cost of ALUNBRIG medication. It provides a Co-pay Assistance Program for commercially insured patients, with potential out-of-pocket costs as low as $0 per prescription. The program has no income requirements and is not valid for patients with government insurance.

Takeda Oncology

The Takeda Oncology Co-Pay Assistance Program assists commercially insured patients with reducing out-of-pocket co-pay costs for ALUNBRIG (brigatinib) medication. This program does not appear to offer any travel assistance or cover travel-related expenses.

Bausch Health (Ortho Dermatologics)

The Targretin Patient Care Program by Bausch Health (Ortho Dermatologics) offers Targretin® prescription products at no cost. It is designed for eligible patients who have a financial need and do not possess prescription insurance coverage, with specific application processes for Medicaid and non-Medicaid patients. This program provides medication assistance and does not cover travel expenses.

Amgen

This page describes financial assistance programs for the TAVNEOS medication itself, including a copay program for commercially insured patients and a patient assistance program for uninsured or underinsured individuals. It does not provide any information about a travel assistance grant, nor does it list any coverage for travel-related expenses.

Johnson & Johnson

The TECVAYLI withMe Savings & Support program provides personalized 1-on-1 support through Care Navigators, who can connect patients to transportation assistance services and other community resources. The program primarily offers cost support for TECVAYLI® medicine, with eligibility varying by insurance type; some components, like the Johnson & Johnson Patient Assistance Program, have income requirements, while others do not.

The Assistance Fund

The Amyloidosis Financial Assistance Program by The Assistance Fund offers financial aid for out-of-pocket costs such as prescription drugs, health insurance premiums, and travel expenses including flights, hotel, meals, and ground transportation. Eligibility requires patients to be U.S. citizens or permanent residents diagnosed with amyloidosis, prescribed an FDA-approved treatment, have prescription coverage, and meet financial criteria based on household income and size. The program is currently accepting waitlist requests.

The Assistance Fund

The Assistance Fund's Fabry Disease Financial Assistance Program provides grants to cover out-of-pocket medical expenses, including prescription drugs, health insurance premiums, therapy administration, disease management, and travel costs (ground/air transportation, meals, hotel) for treatment centers or specialist visits. To qualify, applicants must be U.S. citizens or permanent residents, diagnosed with Fabry disease, prescribed an FDA-approved treatment with prescription coverage, and meet financial eligibility criteria based on household income and size. The program is currently accepting requests to join its enrollment waitlist.

The Assistance Fund (TAF)

This grant provides financial assistance for copays, deductibles, and coinsurance for FDA-approved psoriatic arthritis treatments. It is available to commercially insured and Medicare/Medicaid patients who are residents of the US and Puerto Rico. Income eligibility requirements apply, as it is a needs-based program.

The Assistance Fund

The Assistance Fund: Neurofibromatosis provides financial support for U.S. and Puerto Rico residents to cover copays, coinsurance, deductibles, health insurance premiums, and other incidental medical expenses related to FDA-approved treatments. Applicants must be commercially insured or have Medicare/Medicaid, meet financial needs criteria, and enroll in the program.

The Assistance Fund (TAF)

The Assistance Fund (TAF) offers financial assistance for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH). This grant covers out-of-pocket costs including prescription drug assistance, health insurance premiums, therapy administration, disease management, and travel expenses such as ground transportation, airfare, meals, and hotel stays to treatment centers or specialists. Eligible patients must be U.S. citizens or permanent residents, have a PNH diagnosis, be prescribed an FDA-approved treatment with prescription coverage, and meet TAF's financial eligibility criteria based on household income and size.

The Assistance Fund (TAF)

The Assistance Fund's Duchenne Muscular Dystrophy Financial Assistance Program offers grants to U.S. citizens or permanent residents diagnosed with DMD who are prescribed an FDA-approved treatment and meet financial eligibility criteria based on household income and size. The program covers various out-of-pocket medical expenses, including prescription drug costs, health insurance premiums, therapy administration, and disease management. For travel, it provides financial aid for travel to treatment centers or prescribing physicians, encompassing ground transportation, air travel, meals, and hotel stays.

The Assistance Fund

The Assistance Fund Duchenne Muscular Dystrophy Financial Assistance Program provides grants for out-of-pocket costs including prescription drugs, health insurance premiums, therapy administration, disease management, genetic testing, and travel expenses (ground, air, meals, hotel) to treatment centers or specialists. To qualify, applicants must be U.S. citizens or permanent residents diagnosed with DMD, prescribed an FDA-approved treatment, have prescription coverage, and meet financial eligibility criteria based on household income and size.

The Assistance Fund (TAF)

The MPS II - Hunter Syndrome Financial Assistance Program by The Assistance Fund offers financial aid for out-of-pocket costs including prescription drugs, health insurance premiums, therapy administration, disease management, and travel to treatment or physician appointments (ground transport, air travel, meals, hotel stays). Eligibility requires U.S. citizenship/permanent residency, a diagnosis of Hunter Syndrome, a prescribed FDA-approved treatment with prescription coverage, and meeting financial criteria based on household income and size.

The Assistance Fund

The Assistance Fund Cystic Fibrosis Copay Assistance Program provides financial assistance for out-of-pocket costs, such as copays, deductibles, and coinsurance, for prescribed FDA-approved treatments for cystic fibrosis. Eligible patients must be U.S. citizens or permanent residents, diagnosed with the disease, prescribed an FDA-approved treatment, have prescription coverage, and meet financial eligibility criteria. The program is currently accepting requests to join its enrollment waitlist.

The Assistance Fund

The Hemophilia Financial Assistance Program, offered by The Assistance Fund, provides financial assistance to U.S. citizens or permanent residents diagnosed with hemophilia who are prescribed an FDA-approved treatment and have prescription coverage. It covers out-of-pocket costs such as prescription drugs, health insurance premiums, therapy administration, genetic testing, and ground travel to treatment centers. Applicants must meet financial eligibility criteria based on household income and size.

The Assistance Fund

The Assistance Fund's Hemophilia Financial Assistance Program offers grants to U.S. citizens or permanent residents with hemophilia, covering costs like prescription drugs, health insurance premiums, therapy administration, genetic testing, and ground travel to treatment centers. Applicants must be diagnosed with hemophilia, prescribed an FDA-approved treatment, have prescription coverage, and meet financial eligibility criteria based on household income and size. The program is currently accepting waitlist applications.